Literature DB >> 1551350

Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid.

D O Castell1, C B Dalton, D Becker, J Sinclair, J A Castell.   

Abstract

This study tested the hypothesis that (alginic) acid may have a preferential effect on reflux in the upright position. We evaluated the effect of a compound containing alginic acid plus antacid (extra-strength Gaviscon) versus active control antacid with equal acid-neutralizing capacity on intraesophageal acid exposure following a high-fat meal (61% fat: sausage, egg, and biscuit). In random sequence, each of the 10 volunteers received either alginic acid-antacid or control antacid immediately following and 1, 2, and 3 hr after the meal. The sequence was repeated for both test drugs in the supine and upright positions with constant pH monitoring. Alginic acid-antacid significantly decreased postprandial reflux in the upright position compared to an equal amount of antacid. This effect did not occur in the supine position. These findings support the hypothesis that alginic acid is primarily effective in the upright position and the clinical observations of the effectiveness of alginic acid on daytime reflux symptoms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551350     DOI: 10.1007/bf01307584

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.

Authors:  N J Johnson; E J Boyd; J G Mills; J R Wood
Journal:  Aliment Pharmacol Ther       Date:  1989-06       Impact factor: 8.171

2.  A multicentric, randomized clinical trial of Gaviscon in reflux esophagitis.

Authors:  G McHardy
Journal:  South Med J       Date:  1978-01       Impact factor: 0.954

3.  A comparison of high and low fat meals on postprandial esophageal acid exposure.

Authors:  D J Becker; J Sinclair; D O Castell; W C Wu
Journal:  Am J Gastroenterol       Date:  1989-07       Impact factor: 10.864

4.  Alginate-antacid in the reduction of gastro-oesophageal reflux.

Authors:  C Stanciu; J R Bennett
Journal:  Lancet       Date:  1974-01-26       Impact factor: 79.321

5.  Objective evaluation of an antacid with unusual properties.

Authors:  G L Beckloff; J H Chapman; P Shiverdecker
Journal:  J Clin Pharmacol New Drugs       Date:  1972-01

6.  Effectiveness of foaming antacid in relieving induced heartburn.

Authors:  F L Lanza; V Smith; J A Page-Castell; D O Castell
Journal:  South Med J       Date:  1986-03       Impact factor: 0.954

7.  Gastric acid hypersecretion in refractory gastroesophageal reflux disease.

Authors:  M J Collen; J H Lewis; S B Benjamin
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

8.  Gastroesophageal reflux induced by exercise in healthy volunteers.

Authors:  C S Clark; B B Kraus; J Sinclair; D O Castell
Journal:  JAMA       Date:  1989 Jun 23-30       Impact factor: 56.272

9.  Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux.

Authors:  L F Johnson; T R DeMeester
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

  9 in total
  5 in total

Review 1.  Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Authors:  Katsuhiko Iwakiri; Yoshikazu Kinoshita; Yasuki Habu; Tadayuki Oshima; Noriaki Manabe; Yasuhiro Fujiwara; Akihito Nagahara; Osamu Kawamura; Ryuichi Iwakiri; Soji Ozawa; Kiyoshi Ashida; Shuichi Ohara; Hideyuki Kashiwagi; Kyoichi Adachi; Kazuhide Higuchi; Hiroto Miwa; Kazuma Fujimoto; Motoyasu Kusano; Yoshio Hoshihara; Tatsuyuki Kawano; Ken Haruma; Michio Hongo; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-06-21       Impact factor: 7.527

2.  An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.

Authors:  M A Kwiatek; S Roman; A Fareeduddin; J E Pandolfino; P J Kahrilas
Journal:  Aliment Pharmacol Ther       Date:  2011-05-03       Impact factor: 8.171

3.  Alginate controls heartburn in patients with erosive and nonerosive reflux disease.

Authors:  Edoardo Savarino; Nicola de Bortoli; Patrizia Zentilin; Irene Martinucci; Luca Bruzzone; Manuele Furnari; Santino Marchi; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

Review 4.  Pharmacological management of gastro-oesophageal reflux disease.

Authors:  E C Klinkenberg-Knol; H P Festen; S G Meuwissen
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

5.  Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.

Authors:  Denis Pouchain; Marc-André Bigard; François Liard; Marc Childs; Annick Decaudin; Donna McVey
Journal:  BMC Gastroenterol       Date:  2012-02-23       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.